University of Arkansas, Fayetteville

• NCT07842367

  Phase 2, Recruiting, 210 people, Sep 25, 2026

• NCT07456683

  Completed, 40 people, Mar 6, 2026

• The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder

  Phase 2, Completed, 67 people, Nov 3, 2023

Sources: clinicaltrials.gov